Report Detail
Global Flu Vaccine (Influenza Vaccine) Market Growth 2019-2024
- RnM3002215 |
- 22 February, 2019 |
- Global |
- 132 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
According to this study, over the next five years the Flu Vaccine (Influenza Vaccine) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Flu Vaccine (Influenza Vaccine) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccine (Influenza Vaccine) market by product type, application, key manufacturers and key regions and countries.
This study considers the Flu Vaccine (Influenza Vaccine) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
For Children (6 months to 3 years)
For Adults and Children over 3 years
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Flu Vaccine (Influenza Vaccine) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.
Focuses on the key global Flu Vaccine (Influenza Vaccine) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Flu Vaccine (Influenza Vaccine) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Flu Vaccine (Influenza Vaccine) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Flu Vaccine (Influenza Vaccine) Consumption 2014-2024
- 2.1.2 Flu Vaccine (Influenza Vaccine) Consumption CAGR by Region
- 2.2 Flu Vaccine (Influenza Vaccine) Segment by Type
- 2.2.1 Whole Virus Vaccines
- 2.2.2 Split Virus Vaccines
- 2.2.3 Subunit Vaccines
- 2.2.4 Live Attenuated Virus Vaccines
- 2.3 Flu Vaccine (Influenza Vaccine) Consumption by Type
- 2.3.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Type (2014-2019)
- 2.4 Flu Vaccine (Influenza Vaccine) Segment by Application
- 2.4.1 For Children (6 months to 3 years)
- 2.4.2 For Adults and Children over 3 years
- 2.5 Flu Vaccine (Influenza Vaccine) Consumption by Application
- 2.5.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Flu Vaccine (Influenza Vaccine) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Application (2014-2019)
3 Global Flu Vaccine (Influenza Vaccine) by Players
- 3.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players
- 3.1.1 Global Flu Vaccine (Influenza Vaccine) Sales by Players (2017-2019)
- 3.1.2 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players (2017-2019)
- 3.2 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players
- 3.2.1 Global Flu Vaccine (Influenza Vaccine) Revenue by Players (2017-2019)
- 3.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players (2017-2019)
- 3.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Players
- 3.4 Global Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Flu Vaccine (Influenza Vaccine) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Flu Vaccine (Influenza Vaccine) by Regions
- 4.1 Flu Vaccine (Influenza Vaccine) by Regions
- 4.1.1 Global Flu Vaccine (Influenza Vaccine) Consumption by Regions
- 4.1.2 Global Flu Vaccine (Influenza Vaccine) Value by Regions
- 4.2 Americas Flu Vaccine (Influenza Vaccine) Consumption Growth
- 4.3 APAC Flu Vaccine (Influenza Vaccine) Consumption Growth
- 4.4 Europe Flu Vaccine (Influenza Vaccine) Consumption Growth
- 4.5 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Growth
5 Americas
- 5.1 Americas Flu Vaccine (Influenza Vaccine) Consumption by Countries
- 5.1.1 Americas Flu Vaccine (Influenza Vaccine) Consumption by Countries (2014-2019)
- 5.1.2 Americas Flu Vaccine (Influenza Vaccine) Value by Countries (2014-2019)
- 5.2 Americas Flu Vaccine (Influenza Vaccine) Consumption by Type
- 5.3 Americas Flu Vaccine (Influenza Vaccine) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Flu Vaccine (Influenza Vaccine) Consumption by Countries
- 6.1.1 APAC Flu Vaccine (Influenza Vaccine) Consumption by Countries (2014-2019)
- 6.1.2 APAC Flu Vaccine (Influenza Vaccine) Value by Countries (2014-2019)
- 6.2 APAC Flu Vaccine (Influenza Vaccine) Consumption by Type
- 6.3 APAC Flu Vaccine (Influenza Vaccine) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Flu Vaccine (Influenza Vaccine) by Countries
- 7.1.1 Europe Flu Vaccine (Influenza Vaccine) Consumption by Countries (2014-2019)
- 7.1.2 Europe Flu Vaccine (Influenza Vaccine) Value by Countries (2014-2019)
- 7.2 Europe Flu Vaccine (Influenza Vaccine) Consumption by Type
- 7.3 Europe Flu Vaccine (Influenza Vaccine) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Flu Vaccine (Influenza Vaccine) by Countries
- 8.1.1 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Flu Vaccine (Influenza Vaccine) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Type
- 8.3 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Flu Vaccine (Influenza Vaccine) Distributors
- 10.3 Flu Vaccine (Influenza Vaccine) Customer
11 Global Flu Vaccine (Influenza Vaccine) Market Forecast
- 11.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast (2019-2024)
- 11.2 Global Flu Vaccine (Influenza Vaccine) Forecast by Regions
- 11.2.1 Global Flu Vaccine (Influenza Vaccine) Forecast by Regions (2019-2024)
- 11.2.2 Global Flu Vaccine (Influenza Vaccine) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Flu Vaccine (Influenza Vaccine) Forecast by Type
- 11.8 Global Flu Vaccine (Influenza Vaccine) Forecast by Application
12 Key Players Analysis
- 12.1 CSL
- 12.1.1 Company Details
- 12.1.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CSL News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 Sanofi Pasteur
- 12.3.1 Company Details
- 12.3.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sanofi Pasteur News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
- 12.5 AstraZeneca
- 12.5.1 Company Details
- 12.5.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 AstraZeneca News
- 12.6 Pfizer
- 12.6.1 Company Details
- 12.6.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Pfizer News
- 12.7 Johnson & Johnson
- 12.7.1 Company Details
- 12.7.2 Flu Vaccine (Influenza Vaccine) Product Offered
- 12.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Johnson & Johnson News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Flu Vaccine (Influenza Vaccine) . Industry analysis & Market Report on Flu Vaccine (Influenza Vaccine) is a syndicated market report, published as Global Flu Vaccine (Influenza Vaccine) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Flu Vaccine (Influenza Vaccine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
